240 related articles for article (PubMed ID: 21232042)
1. Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists.
Capelli AM; Castelletti L; Chen YH; Van der Keyl H; Pucci L; Oliosi B; Salvagno C; Bertani B; Gotti C; Powell A; Mugnaini M
Br J Pharmacol; 2011 May; 163(2):313-29. PubMed ID: 21232042
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
[TBL] [Abstract][Full Text] [Related]
3. Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors.
van Hout M; Klein J; Ahring PK; Brown DT; Thaneshwaran S; Dos Santos AB; Jensen AA; Kohlmeier KA; Christophersen P; Dyhring T
Biochem Pharmacol; 2020 Apr; 174():113788. PubMed ID: 31887290
[TBL] [Abstract][Full Text] [Related]
4. Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.
Brunzell DH; McIntosh JM; Papke RL
Ann N Y Acad Sci; 2014 Oct; 1327(1):27-45. PubMed ID: 24730978
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and functional comparisons of α6/α3β2β3-nAChRs and α4β2-nAChRs heterologously expressed in the human epithelial SH-EP1 cell line.
Chen DJ; Gao FF; Ma XK; Shi GG; Huang YB; Su QX; Sudweeks S; Gao M; Dharshaun T; Eaton JB; Chang YC; Mcintosh JM; Lukas RJ; Whiteaker P; Steffensen SC; Wu J
Acta Pharmacol Sin; 2018 Oct; 39(10):1571-1581. PubMed ID: 29795357
[TBL] [Abstract][Full Text] [Related]
6. High-Throughput Patch Clamp Screening in Human α6-Containing Nicotinic Acetylcholine Receptors.
Armstrong LC; Kirsch GE; Fedorov NB; Wu C; Kuryshev YA; Sewell AL; Liu Z; Motter AL; Leggett CS; Orr MS
SLAS Discov; 2017 Jul; 22(6):686-695. PubMed ID: 28298165
[TBL] [Abstract][Full Text] [Related]
7. α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.
Hone AJ; Scadden M; Gajewiak J; Christensen S; Lindstrom J; McIntosh JM
Mol Pharmacol; 2012 Nov; 82(5):972-82. PubMed ID: 22914547
[TBL] [Abstract][Full Text] [Related]
8. Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptors.
Sandager-Nielsen K; Ahring PK; Klein J; van Hout M; Thaneshwaran S; Dos Santos AB; Jacobsen TA; Amrutkar DV; Peters D; Jensen AA; Kohlmeier KA; Christophersen P; Dyhring T
Biochem Pharmacol; 2020 Apr; 174():113786. PubMed ID: 31887288
[TBL] [Abstract][Full Text] [Related]
9. Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.
Gotti C; Moretti M; Clementi F; Riganti L; McIntosh JM; Collins AC; Marks MJ; Whiteaker P
Mol Pharmacol; 2005 Jun; 67(6):2007-15. PubMed ID: 15749993
[TBL] [Abstract][Full Text] [Related]
10. Analysis of rare variations reveals roles of amino acid residues in the N-terminal extracellular domain of nicotinic acetylcholine receptor (nAChR) alpha6 subunit in the functional expression of human alpha6*-nAChRs.
Dash B; Li MD
Mol Brain; 2014 May; 7():35. PubMed ID: 24886653
[TBL] [Abstract][Full Text] [Related]
11. Biophysical and pharmacological characterization of α6-containing nicotinic acetylcholine receptors expressed in HEK293 cells.
Rasmussen AH; Strøbæk D; Dyhring T; Jensen ML; Peters D; Grunnet M; Timmermann DB; Ahring PK
Brain Res; 2014 Jan; 1542():1-11. PubMed ID: 24157862
[TBL] [Abstract][Full Text] [Related]
12. α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.
van Hout M; Valdes A; Christensen SB; Tran PT; Watkins M; Gajewiak J; Jensen AA; Olivera BM; McIntosh JM
Neuropharmacology; 2019 Oct; 157():107691. PubMed ID: 31255696
[TBL] [Abstract][Full Text] [Related]
13. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
Rollema H; Hurst RS
Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
[TBL] [Abstract][Full Text] [Related]
14. Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.
McIntosh JM; Azam L; Staheli S; Dowell C; Lindstrom JM; Kuryatov A; Garrett JE; Marks MJ; Whiteaker P
Mol Pharmacol; 2004 Apr; 65(4):944-52. PubMed ID: 15044624
[TBL] [Abstract][Full Text] [Related]
15. Characterizing functional α6β2 nicotinic acetylcholine receptors in vitro: mutant β2 subunits improve membrane expression, and fluorescent proteins reveal responsive cells.
Xiao C; Srinivasan R; Drenan RM; Mackey ED; McIntosh JM; Lester HA
Biochem Pharmacol; 2011 Oct; 82(8):852-61. PubMed ID: 21609715
[TBL] [Abstract][Full Text] [Related]
16. Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice.
Sanjakdar SS; Maldoon PP; Marks MJ; Brunzell DH; Maskos U; McIntosh JM; Bowers MS; Damaj MI
Neuropsychopharmacology; 2015 Jan; 40(2):350-60. PubMed ID: 25035086
[TBL] [Abstract][Full Text] [Related]
17. Functional nicotinic acetylcholine receptors containing α6 subunits are on GABAergic neuronal boutons adherent to ventral tegmental area dopamine neurons.
Yang K; Buhlman L; Khan GM; Nichols RA; Jin G; McIntosh JM; Whiteaker P; Lukas RJ; Wu J
J Neurosci; 2011 Feb; 31(7):2537-48. PubMed ID: 21325521
[TBL] [Abstract][Full Text] [Related]
18. Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.
Sumithran SP; Crooks PA; Xu R; Zhu J; Deaciuc AG; Wilkins LH; Dwoskin LP
AAPS J; 2005 Aug; 7(1):E201-17. PubMed ID: 16146341
[TBL] [Abstract][Full Text] [Related]
19. Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology.
Yang KC; Jin GZ; Wu J
Acta Pharmacol Sin; 2009 Jun; 30(6):740-51. PubMed ID: 19498417
[TBL] [Abstract][Full Text] [Related]
20. Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras.
Papke RL; Dwoskin LP; Crooks PA; Zheng G; Zhang Z; McIntosh JM; Stokes C
Neuropharmacology; 2008 Jun; 54(8):1189-200. PubMed ID: 18448138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
